NSE
Godavari Biorefineries LimitedGODAVARIB
Godavari Biorefineries Limited is a leading manufacturer of chemicals, pharmaceuticals, and food products in India. The company operates primarily through its manufacturing and trading businesses.
| Key products | Pharmaceuticals, Food Products, Chemicals |
|---|---|
| Geography | India |
| Competitors | Grasim Industries, Reliance Industries, Hindustan National Glass, IOL Chemicals & Pharmaceuticals |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹27.1 Cr
Institutional buyers
0 in / 3 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹15.1 Cr | 267 | — | — | — | — |
| 2 | MOBIKWIK | +₹5.2 Cr | 355 | — | — | — | — |
| 3 | MTNL | +₹0.1 Cr | 26 | — | — | — | — |
| 4 | GATECH | −₹0.3 Cr | 77 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹7.9 Cr | 177 | — | — | — | — |
| 7 | GODAVARIBThis | −₹14.9 Cr | 6 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-16FilingGodavari Biorefineries Limited has informed the Exchange about Japanese Patent Office granted our patent, "5-HGeneral
- 2026-02-27BulkBUY · ₹8.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-02-27BulkSELL · ₹8.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-02-27NetDay net −₹0 Cr
- 2025-10-28BulkBUY · ₹7.1 CrCHAUBARA EATS PRIVATE LIMITED
- 2025-10-28BulkSELL · ₹7.1 CrCHAUBARA EATS PRIVATE LIMITED
- 2025-07-04BulkSELL · ₹8.2 Cr360 ONE EQUITY OPPORTUNITY FUND
- 2025-07-04BulkSELL · ₹6.6 CrTURNAROUND OPPORTUNITIES FUND
- 2025-07-04NetDay net −₹14.9 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2GeneralNeutral
Japanese Patent Office granted our patent, "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER
Source PDF →
6 deals · 2025-07-04 → 2026-02-27
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-02-27 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | BUY | ₹8.5 Cr |
| 2026-02-27 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | SELL | ₹8.5 Cr |
| 2025-10-28 | CHAUBARA EATS PRIVATE LIMITED | HNI / other | BUY | ₹7.1 Cr |
| 2025-10-28 | CHAUBARA EATS PRIVATE LIMITED | HNI / other | SELL | ₹7.1 Cr |
| 2025-07-04 | 360 ONE EQUITY OPPORTUNITY FUND | Institution | SELL | ₹8.2 Cr |
| 2025-07-04 | TURNAROUND OPPORTUNITIES FUND | Institution | SELL | ₹6.6 Cr |
6 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on GODAVARIB
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.